Archive: August, 2022

DoD Awards Synthetic Human Antibody Prototype Agreement to Treat High-Priority Toxins and Pathogens
August 24, 2022

FDA Approves New Drug Application for the DoD’s Advanced Anticonvulsant System Program
August 24, 2022
midazolam injection autoinjector

Senior U.S. Army civilian retires from Department of Defense's premier all hazards command
August 19, 2022
Dr. Mark W. Fishback retired from the 20th Chemical, Biological, Radiological, Nuclear, Explosives (CBRNE) Command as the deputy to the commanding general and senior U.S. Army civilian


Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.  



JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.